Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Thoracic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Glioblastoma 80 Brain Neoplasms 33 Gliosarcoma 30 Glioma 24 Astrocytoma 18 Central Nervous System Neoplasms 11 Medulloblastoma 9 Oligodendroglioma 5 Neuroblastoma 5 Ganglioneuroblastoma 5 Ependymoma 4 Diffuse Intrinsic Pontine Glioma 4 Neoplasms 3 Breast Neoplasms 3 Meningeal Carcinomatosis 2 Melanoma 2 Untreated Childhood Anaplastic Astrocytoma 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Recurrence 1 Rare Diseases 1 Prostatic Neoplasms 1 Pinealoma 1 Obesity 1 Neurofibromatosis 1 1

Interventions

Temozolomide 23 Bevacizumab 18 Cyclophosphamide 9 Carboplatin 7 Lomustine 6 Irinotecan 6 3-Iodobenzylguanidine 6 Topotecan 5 Radiotherapy 5 Filgrastim 5 Radiosurgery 4 Nivolumab 4 Everolimus 4 Etoposide 4 Busulfan 4 sonidegib 3 pembrolizumab 3 olaparib 3 fludarabine phosphate 3 fludarabine 3 antineoplaston AS 2-1 3 antineoplaston A10 3 Vincristine 3 Thiotepa 3 Sirolimus 3 Melphalan 3 IL13-PE38 3 Drug Therapy 3 Antilymphocyte Serum 3 verubulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Radiation × CNS × Clear all

NCT03970447 2026-05-15

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡